High-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements represent a quite recently defined entity of lymphoma with aggressive nature, high genomic complexity and poor prognosis [9]. Here, BCL2 is linked to B-cell non-Hodgkin lymphoma.